Hinge Health, Inc. Selling and Marketing Expense
Hinge Health, Inc. (HNGE) reported Selling and Marketing Expense of $81.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-06
- Hinge Health, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $81.41M, a 44.71% decline year-over-year.
- Hinge Health, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $68.80M, a 47.28% increase year-over-year.
- Hinge Health, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $59.49M, a 67.80% increase year-over-year.
- Hinge Health, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $63.52M, a 42.52% increase year-over-year.
- Hinge Health, Inc. selling and marketing expense for fiscal 2025 was $316.95M, a 89.73% increase from fiscal 2024.
- Hinge Health, Inc. selling and marketing expense for fiscal 2024 was $167.06M, a 13.17% increase from fiscal 2023.
- Hinge Health, Inc. selling and marketing expense for fiscal 2023 was $147.62M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $81.41M 10-Q · filed 2026-08-06 | $150.21M 10-Q · filed 2026-08-06 | $209.70M derived: sum of 3 quarters · filed 2026-08-06 | $273.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $68.80M 10-Q · filed 2026-05-07 | $128.29M derived: sum of 2 quarters · filed 2026-05-07 | $191.81M derived: sum of 3 quarters · filed 2026-05-07 | $339.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $59.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $123.01M derived: sum of 2 quarters · filed 2026-03-03 | $270.24M derived: sum of 3 quarters · filed 2026-08-06 | $316.95M 10-K · filed 2026-03-03 |
| 2025-09-30 | $63.52M 10-Q · filed 2025-11-07 | $210.75M derived: sum of 2 quarters · filed 2026-08-06 | $257.46M 10-Q · filed 2025-11-07 | $292.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $147.23M 10-Q · filed 2026-08-06 | $193.94M 10-Q · filed 2026-08-06 | $229.40M derived: sum of 3 quarters · filed 2026-08-06 | $273.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $46.72M 10-Q · filed 2026-05-07 | $82.17M derived: sum of 2 quarters · filed 2026-05-07 | $126.74M derived: sum of 3 quarters · filed 2026-05-07 | $171.63M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $35.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $80.02M derived: sum of 2 quarters · filed 2026-03-03 | $124.92M derived: sum of 3 quarters · filed 2026-03-03 | $167.06M 10-K · filed 2026-03-03 |
| 2024-09-30 | $44.57M 10-Q · filed 2025-11-07 | $89.46M derived: sum of 2 quarters · filed 2025-11-07 | $131.61M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $44.89M 10-Q · filed 2025-08-11 | $87.04M 10-Q · filed 2025-08-11 | ||
| 2023-12-31 | $147.62M 10-K · filed 2026-03-03 |